Shopping Cart 0
Cart Subtotal
USD 0

Revalesio Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targeted on asthma, Parkinson's disease and acute myocardial infarctions, among others. Revalesio develops RNS60 a processing normal, medical-grade, isotonic saline, which is used as an ingredient in development of therapeutics through its proprietary charge-stabilized nanostructure technology. The company partners with academic research institutes and commercial development companies to develop its products. Revalesio is headquartered in Tacoma, Washington, the US.

Revalesio Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Revalesio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Revalesio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Revalesio Corp, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Revalesio Raises USD14 Million in Venture Financing 10

Revalesio Raises USD 13.5 Million In Venture Financing 11

Revalesio Raises USD 10.6 Million In Venture Financing 12

Revalesio Corp-Key Competitors 13

Revalesio Corp-Locations And Subsidiaries 14

Head Office 14

Recent Developments 15

Product News 15

03/06/2018: RNS60 Promotes Myelination of Nanofibers by Oligodendrocytes 15

Product Approvals 16

Sep 20, 2017: FDA Grants Revalesio Orphan Drug Status For Als Investigational Drug RNS60 16

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

Revalesio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Revalesio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Revalesio Corp, Pharmaceuticals & Healthcare, Key Facts 2

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Revalesio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Revalesio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Revalesio Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Revalesio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Revalesio Raises USD14 Million in Venture Financing 10

Revalesio Raises USD 13.5 Million In Venture Financing 11

Revalesio Raises USD 10.6 Million In Venture Financing 12

Revalesio Corp, Key Competitors 13

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Revalesio Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.